A study of drug interactions between Gemzar, Citodon Forte, Cetiprin Novum, Estradurin for a Male patient aged 79

This is a personalized study of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin drug interactions for a 79 year old male patient. The study is created by eHealthMe based on 16 reports from FDA.

Do you have chronic disease and take multiple drugs? eHealthMe can monitor your drugs and notify you when there are serious drug reactions detected. Our original studies have been used on premier medical publications. The monitor will be personalized to your gender and age. Start now

What are the drugs

Gemzar has active ingredients of gemcitabine hydrochloride. It is used in pancreatic carcinoma.

Citodon forte has active ingredients of fluorometholone.

Cetiprin novum has active ingredients of mestranol; norethindrone.

Estradurin has active ingredients of polyestradiol phosphate. It is used in prostate cancer.

On Apr, 14, 2013: 16 people who reported to have interactions when taking Gemzar, Citodon Forte, Cetiprin Novum, Estradurin are studied

Information of the patient in this study:

Age: 79

Gender: male

Conditions: Prostate Cancer

Drugs taking:
- Gemzar: used for < 1 month
- Citodon Forte
- Cetiprin Novum
- Estradurin

Drug interactions have: Weight Decreased, Oedema Peripheral, Obstructive Uropathy, Hydronephrosis, Haemoglobin Decreased, Blood Urea Increased, Blood Creatinine Increased, Asthenia

eHealthMe real world results:

For males aged 79 (±5):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by males aged 79 (±5) in the use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by males aged 79 (±5) in long term use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by people in the use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by people in long term use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: study your drugs

You can also:

• get notified of updates of this study
• post a comment
• let eHealthMe monitor your drugs
• get our mobile app: never miss a symptom, compare it with patients like me in real time, and discuss it with doctors later
• still have questions? Check any related studies below

Alternative drugs:

• Prostate Cancer (16 drugs) (updated 1 week ago)

Recent related drug checks on eHealthMe:

• A study of drug interactions between Enantyum, Pentoxifilina, Flumil, Salmeterol, Omeprazole, Doxium Forte, Sorafenib, Cisplatin, Gemcitabine Hcl, Codeine Sul Tab, Fluconazole for a patient with Pain, Vasodilatation, Nasopharyngitis, Chronic Obstructive Pulmonary Disease, Prophylaxis Against Gastrointestinal Ulcer, Cerebrovascular Accident Prophylaxis, Non-small Cell Lung Cancer, Mucosal Inflammation. The patient has Thrombosis
• A study of drug interactions between Radiation Therapy, Rinderon, Anpec, Acinon, Gemzar, Kenalog, Posterisan Forte, Magnesium Oxide, Nauzelin, Monilac, Loxonin for a patient with Pancreatic Carcinoma Stage Iv, Decreased Appetite, Cancer Pain, Prophylaxis Against Gastrointestinal Ulcer, Stomatitis, Haemorrhoids, Constipation, Nausea. The patient has Interstitial Lung Disease
• A study of drug interactions between Radiation Therapy, Rinderon, Anpec, Acinon, Gemzar, Posterisan Forte, Magnesium Oxide, Nauzelin, Monilac, Loxonin, Kenalog for a patient with Pancreatic Carcinoma Stage Iv, Decreased Appetite, Cancer Pain, Prophylaxis Against Gastrointestinal Ulcer, Haemorrhoids, Constipation, Nausea, Stomatitis. The patient has Interstitial Lung Disease
• A study of drug interactions between Zofran, Gemcitabine, Cisplatin, Cetuximab, Compazine, Minocycline Hcl, Ortho-est, Decadron, Vitamin D, Calcium, Norvasc, Xanax for a patient with Nausea, Transitional Cell Carcinoma. The patient has Deep Vein Thrombosis
• A study of drug interactions between Gemcitabine, Minocycline Hcl, Vitamin D, Zofran, Cisplatin, Cetuximab, Compazine, Ortho-est, Decadron, Calcium, Norvasc, Xanax for a patient with Transitional Cell Carcinoma, Nausea. The patient has Deep Vein Thrombosis
• A study of drug interactions between Pentoxifilina, Flumil, Enantyum, Omeprazol, Fluconazole, Cisplatin, Doxium Forte, Codeine Sul Tab, Salmeterol, Gemcitabine Hcl, Sorafenib for a patient with Vasodilatation, Nasopharyngitis, Pain, Mucosal Inflammation, Non-small Cell Lung Cancer, Cerebrovascular Accident Prophylaxis, Chronic Obstructive Pulmonary Disease, Prophylaxis Against Gastrointestinal Ulcer. The patient has Peripheral Arterial Occlusive Disease
• A study of drug interactions between Kalium Retard, Metoclopramide, Bronchoretard Forte, Theophylline, Allopurinol, Gemcitabine Hcl, Bevacizumab, Cisplatin, Lopedium, Kalinor, Pantozol for a patient with Lung Neoplasm. The patient has Unevaluable Event, Pyrexia, Dehydration
• A study of drug interactions between Durabac Forte, Avandia, Vistaril for a patient with Diabetes Mellitus. The patient has Superior Sagittal Sinus Thrombosis

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent drug studies on eHealthMe: